Source:http://linkedlifedata.com/resource/pubmed/id/17406976
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2007-7-20
|
pubmed:abstractText |
The present study investigated the role of angiotensin receptors (AT-R) in the survival and inflammatory response of astroglia upon hypoxic injury. Exposure of rat astroglial primary cultures (APC) to hypoxic conditions (HC) led to decreased viability of the cells and to a 3.5-fold increase in TNF-alpha release. AT-R type1 (AT1-R) antagonist losartan and its metabolite EXP3174 decrease the LDH release (by 36 +/- 9%; 45 +/- 6%) from APC under HC. Losartan diminished TNF-alpha release (by 40 +/- 15%) and the number of TUNEL-cells by 204 +/- 38% under HC, alone and together with angiotensin II (ATII), while EXP3174 was dependent on ATII for its effect on TNF-alpha. The AT2-R antagonist, PD123.319, did not influence the release of LDH and TNF-alpha under normoxic (NC) and HC. These data suggest that AT1-R may decrease the susceptibility of astrocytes to hypoxic injury and their propensity to release TNF-alpha. AT1-R antagonists may therefore be of therapeutic value during hypoxia-associated neurodegeneration.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/EXP3174,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Losartan,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Angiotensin, Type 1,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Angiotensin, Type 2,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0364-3190
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1489-98
|
pubmed:meshHeading |
pubmed-meshheading:17406976-Animals,
pubmed-meshheading:17406976-Astrocytes,
pubmed-meshheading:17406976-Cell Hypoxia,
pubmed-meshheading:17406976-Cells, Cultured,
pubmed-meshheading:17406976-Imidazoles,
pubmed-meshheading:17406976-Losartan,
pubmed-meshheading:17406976-Rats,
pubmed-meshheading:17406976-Rats, Wistar,
pubmed-meshheading:17406976-Receptor, Angiotensin, Type 1,
pubmed-meshheading:17406976-Receptor, Angiotensin, Type 2,
pubmed-meshheading:17406976-Tetrazoles,
pubmed-meshheading:17406976-Tumor Necrosis Factor-alpha
|
pubmed:year |
2007
|
pubmed:articleTitle |
Angiotensin receptor type 1 blockade in astroglia decreases hypoxia-induced cell damage and TNF alpha release.
|
pubmed:affiliation |
Department of Clinical Pharmacology, University Hospital of Tuebingen, Otfried-Mueller Strasse 45, 72076 Tuebingen, Germany. lusine.danielyan@med.uni-tuebingen.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|